BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2543085)

  • 21. Blocking (suppressor) factors, immune complexes, and extracorporeal immunoadsorption in tumor immunity.
    Hellström KE; Hellström I; Snyder HW; Balint JP; Jones FR
    Contemp Top Immunobiol; 1985; 15():213-38. PubMed ID: 2992879
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of treatment with cobra venom factor on experimentally induced feline leukemia.
    Kraut EH; Rojko JL; Olsen RG; Tuomari DL
    Am J Vet Res; 1987 Jul; 48(7):1063-6. PubMed ID: 2820273
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective removal of antigen-complexed IgG from cat plasma by adsorption onto a protein A-silica matrix.
    Snyder HW; Ernst NR; Grosmaire LS; Balint JP; Yoshida LH; Jones FR
    J Immunol Methods; 1987 Aug; 101(2):209-17. PubMed ID: 3039006
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correcting immune imbalance: the use of Prosorba column treatment for immune disorders.
    Levy J; Degani N
    Ther Apher Dial; 2003 Apr; 7(2):197-205. PubMed ID: 12918943
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Experience with protein A-immunoadsorption in treatment-resistant adult immune thrombocytopenic purpura.
    Snyder HW; Cochran SK; Balint JP; Bertram JH; Mittelman A; Guthrie TH; Jones FR
    Blood; 1992 May; 79(9):2237-45. PubMed ID: 1571540
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating immune complexes associated with naturally occurring lymphosarcoma in pet cats.
    Day NK; O'Reilly-Felice C; Hardy WD; Good RA; Witkin SS
    J Immunol; 1980 Dec; 125(6):2363-6. PubMed ID: 6253567
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute glomerulonephritis occurring during immunoadsorption with staphylococcal protein A column (Prosorba).
    Iglesias J; D'Agati VD; Levine JS
    Nephrol Dial Transplant; 2004 Dec; 19(12):3155-9. PubMed ID: 15575004
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence for proteolytic cleavage of covalently bound protein A from a silica based extracorporeal immunoadsorbent and lack of relationship to treatment effects.
    Balint JP; Jones FR
    Transfus Sci; 1995 Mar; 16(1):85-94. PubMed ID: 10155709
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunologic thrombocytopenic purpura in human immunodeficiency virus--seropositive patients with hemophilia. Comparison with patients with classic autoimmune thrombocytopenic purpura, homosexuals with thrombocytopenia, and narcotic addicts with thrombocytopenia.
    Karpatkin S; Nardi MA
    J Lab Clin Med; 1988 Apr; 111(4):441-8. PubMed ID: 3258345
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of circulating immune complexes by a Clq/protein A-ELISA during the preneoplastic stages of feline leukemia virus infection.
    Tuomari DL; Olsen RG; Singh VK; Kraut EH
    Vet Immunol Immunopathol; 1984 Oct; 7(3-4):227-38. PubMed ID: 6095518
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protein A immunotherapy in the treatment of cancer: an update.
    Messerschmidt GL; Henry DH; Snyder HW; Bertram J; Mittelman A; Ainsworth S; Fiore J; Viola MV; Louie J; Ambinder E
    Semin Hematol; 1989 Apr; 26(2 Suppl 1):19-24. PubMed ID: 2658096
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of protein A columns in the treatment of cancer and allied diseases.
    Ciavarella D
    Int J Clin Lab Res; 1992; 21(3):210-3. PubMed ID: 1591370
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ex vivo perfusion of plasma over protein A columns in human mammary adenocarcinoma. Evidence for a protein A leaking by radioimmunoassay.
    Kinet JP; Hunt J; Foidart JB; Desoroux A; Mahieu P
    Eur J Clin Invest; 1986 Feb; 16(1):43-9. PubMed ID: 3084271
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of antigen involved in circulating immune complexes in patients with idiopathic thrombocytopenic purpura.
    Kurata Y; Hayashi S; Aochi H; Nagamine K; Oshida M; Mizutani H; Tomiyama Y; Tsubakio T; Yonezawa T; Tarui S
    Clin Exp Immunol; 1987 Feb; 67(2):293-9. PubMed ID: 3608226
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New trends in specific immunoadsorption.
    Ullrich H; Kuehnl P
    Transfus Apher Sci; 2004 Jun; 30(3):223-31. PubMed ID: 15172628
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current topics on immunoadsorption therapy.
    Nakaji S
    Ther Apher; 2001 Aug; 5(4):301-5. PubMed ID: 11724516
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Leukocytoclastic vasculitis following staphylococcal protein A column immunoadsorption therapy. Two cases and a review of the literature.
    Arbiser JL; Dzieczkowski JS; Harmon JV; Duncan LM
    Arch Dermatol; 1995 Jun; 131(6):707-9. PubMed ID: 7778924
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Presence of fucolipid antigens with mono- and dimeric X determinant (Lex) in the circulating immune complexes of patients with adenocarcinoma.
    Singhal AK; Singhal MC; Nudelman E; Hakomori S; Balint JP; Grant CK; Snyder HW
    Cancer Res; 1987 Nov; 47(21):5566-71. PubMed ID: 2444333
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Circulating immune complexes in breast cancer].
    Abecassis J; Petit JC; Eber M; Klein T; Rodier D; Janser JC; Methlin G
    Bull Cancer; 1985; 72(1):42-7. PubMed ID: 3872691
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Significance of circulating immune complexes in pulmonary tuberculosis.
    Samuel AM; Ashtekar MD; Ganatra RD
    Clin Exp Immunol; 1984 Nov; 58(2):317-24. PubMed ID: 6437714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.